Nucleic Acid Extraction Instruments And Reagents Market Report 2026

Nucleic Acid Extraction Instruments And Reagents Market Overview

• Nucleic Acid Extraction Instruments And Reagents market size has reached to $4.97 billion in 2025 • Expected to grow to $8.78 billion in 2030 at a compound annual growth rate (CAGR) of 12.2% • Growth Driver: Rising Burden Of Chronic Non Communicable Diseases Driving Demand For Nucleic Acid Extraction Instruments And Reagents • Market Trend: Innovation In Nucleic Acid Extraction With LGC Biosearch Technologies Launches Rapid Sbeadex Lightning Method • North America was the largest region in 2025.

What Is Covered Under Nucleic Acid Extraction Instruments And Reagents Market?

Nucleic acid extraction instruments and reagents refer to the tools and substances used in the process of isolating and purifying nucleic acids, such as DNA or RNA, from biological samples. Nucleic acid extraction instruments typically include specialized equipment designed to perform various steps of the extraction process. These instruments and reagents are essential in molecular biology, genetics, and diagnostic laboratories. The main nucleic acid extraction instruments and reagents types are instruments, spin columns, beads or magnetic beads, automated nucleic acid extraction systems, extraction kits and reagents and consumables, and others. An instrument refers to a device or tool designed and used for various purposes, such as measurement, analysis, or experimentation. The various extraction types are DNA extraction, DNA or RNA extraction, and RNA extraction, which are extracted by solution-based methods, and solid-phase-based methods. The end users are academic research institutes, hospitals and diagnostic centers, the pharmaceutical and biotechnology industry, contract research organizations (CROs), and others.

What Is The Nucleic Acid Extraction Instruments And Reagents Market Growth Forecast?

The nucleic acid extraction instruments and reagents market size is expected to see rapid growth in the next few years. It will grow to $8.78 billion in 2030 at a compound annual growth rate (CAGR) of 12.2%. The growth in the forecast period can be attributed to increasing demand for personalized medicine, expansion of infectious disease testing, growing investments in genomics research, rising adoption of fully automated laboratory systems, increased focus on rapid diagnostic turnaround times. Major trends in the forecast period include increasing adoption of automated extraction systems, rising demand for high-throughput nucleic acid processing, growing use of magnetic bead-based extraction methods, expansion of integrated sample-to-result platforms, enhanced focus on extraction accuracy and reproducibility.

Global Nucleic Acid Extraction Instruments And Reagents Market Segmentation

1) By Type: Instruments, Spin Columns, Beads Or Magnetic Beads, Automated Nucleic Acid Extraction Systems, Extraction Kits And Reagents And Consumables, Other Types 2) By Extraction Type: DNA Extraction, DNA Or RNA Extraction, RNA Extraction 3) By Method: Solution-Based Methods, Solid-Phase-Based Methods 4) By End User: Academic Research Institutes, Hospitals And Diagnostic Centers, Pharmaceutical And Biotechnology Industry, Contract Research Organizations (CROs), Other End Users Subsegments: 1) By Instruments: Manual Extraction Instruments, Automated Extraction Instruments, Specialized Nucleic Acid Extractors 2) By Spin Columns: Standard, High-Throughput, Specialized 3) By Beads Or Magnetic Beads: Silica-Based Beads, Magnetic Beads For DNA Or RNA Extraction, Functionalized Beads For Nucleic Acid Binding 4) By Automated Nucleic Acid Extraction Systems: Fully Automated Systems, Semi-Automated Systems 5) By Extraction Kits And Reagents And Consumables: DNA Extraction Kits, RNA Extraction Kits, Reagents For Nucleic Acid Purification, Consumables 6) By Other Types: Specialized Extraction Methods, Hybrid Methods

What Is The Driver Of The Nucleic Acid Extraction Instruments And Reagents Market?

The increasing prevalence of chronic non communicable diseases (NCDs) is expected to propel the growth of the nucleic acid extraction instruments and reagents market going forward. Chronic non communicable diseases are long-term medical conditions, including cardiovascular diseases, cancers, chronic respiratory diseases, and diabetes, which progress slowly and significantly contribute to global morbidity and mortality. Nucleic acid extraction instruments and reagents are critical in this context, as they enable molecular diagnostics, genetic testing, biomarker analysis, pharmacogenomic profiling, and disease monitoring, all of which support better understanding and management of these chronic conditions. For instance, in January 2024, according to the American Heart Association, a US-based non-profit organization, the age-adjusted death rate from cardiovascular disease increased to 233.3 per 100,000 in 2024, up 4.0% from 224.4 per 100,000 in 2023. Therefore, the rising prevalence of chronic non communicable diseases is driving the growth of the nucleic acid extraction instruments and reagents industry.

Key Players In The Global Nucleic Acid Extraction Instruments And Reagents Market

Major companies operating in the nucleic acid extraction instruments and reagents market are Thermo Fisher Scientific Inc., F Hoffmann-La Roche Ltd., Merck Group, Corning Incorporated, Agilent Technologies Inc., PerkinElmer, Beckman Coulter, Bio-Rad Laboratories Inc., Qiagen NV, Eppendorf AG, LGC Biosearch Technologies, Promega Corporation, RBC Bioscience Corp., Takara Bio Inc., Meridian Bioscience, Bioneer Corporation, Macherey-Nagel, New England Biolabs, Miltenyi Biotec, Omega Bio-tek, BioVision Inc., Norgen Biotek Corp., Biosan Laboratories Inc., G-Biosciences, ADS Biotec Inc., BioChain Institute Inc., Lucigen Corporation

Global Nucleic Acid Extraction Instruments And Reagents Market Trends and Insights

Major companies operating in the nucleic acid extraction instruments and reagents market are focusing on developing innovative solutions, such as nucleic acid extraction systems, to emphasize their focus on innovation and addressing specific market needs. Nucleic acid extraction systems refer to a set of laboratory tools and technologies designed to isolate and purify nucleic acids (DNA and RNA) from biological samples, such as blood, tissues, cells, and other fluids. For instance, in January 2024, LGC Biosearch Technologies, a UK-based biotechnology company, launched the sbeadex Lightning nucleic acid extraction method, which revolutionizes DNA purification by enabling high-purity extraction from plant and animal samples in just 5 minutes. This innovative method simplifies the traditional five-step process into three steps, bind, wash, and elute, resulting in a time savings of up to 40 minutes per sample and increasing throughput by as much as tenfold. The extracted DNA typically achieves high purity, with 260/280 ratios between 1.7 and 2, making it suitable for applications like PCR and next-generation sequencing (NGS).

What Are Latest Mergers And Acquisitions In The Nucleic Acid Extraction Instruments And Reagents Market?

In February 2025, Bio-Rad Laboratories Inc., a US-based biotechnology and life-science research company, acquired Stilla Technologies SAS for $ 225 million, with additional contingent milestone payments of up to US$ 50 million. Through this acquisition, Bio-Rad aims to enhance its digital PCR (dPCR) capabilities by integrating Stilla’s high-precision multiplex digital PCR platforms into its product portfolio. Stilla Technologies SAS is a France-based company that develops digital PCR instruments and assays used in genomics research, rare mutation detection, liquid biopsy analysis, and nucleic acid quantification.

Regional Outlook

North America was the largest region in the nucleic acid extraction instruments and reagents market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Nucleic Acid Extraction Instruments And Reagents Market?

The nucleic acid extraction instruments and reagents market consists of revenues earned by entities by providing nucleic acid extraction instruments and reagents services such as data management and analysis, and laboratory information management systems. The market value includes the value of related goods sold by the service provider or included within the service offering. The nucleic acid extraction instruments and reagents market also includes sales of centrifuges, thermal cyclers, and robotic platforms, which are used in providing nucleic acid extraction instruments and reagents services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.